Cargando…

Murine double minute 2, a potential p53-independent regulator of liver cancer metastasis

Hepatocellular carcinoma (HCC) has emerged as one of the most commonly diagnosed forms of human cancer; yet, the mechanisms underlying HCC progression remain unclear. Unlike other cancers, systematic chemotherapy is not effective for HCC patients, while surgical resection and liver transplantation a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ranjan, Atul, Bera, Kaustav, Iwakuma, Tomoo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609474/ https://www.ncbi.nlm.nih.gov/pubmed/28944296 http://dx.doi.org/10.20517/2394-5079.2015.67

Ejemplares similares

Emerging Non-Canonical Functions and Regulation of p53
por: Ranjan, Atul, et al.
Publicado: (2018)

Non-Canonical Cell Death Induced by p53
por: Ranjan, Atul, et al.
Publicado: (2016)

Roles of p53 in extrinsic factor-induced liver carcinogenesis
por: Link, Tim, et al.
Publicado: (2017)

p53 as a Regulator of Lipid Metabolism in Cancer
por: Parrales, Alejandro, et al.
Publicado: (2016)

Targeting Oncogenic Mutant p53 for Cancer Therapy
por: Parrales, Alejandro, et al.
Publicado: (2015)

Drugs Targeting p53 Mutations with FDA Approval and in Clinical Trials
por: Nishikawa, Shigeto, et al.
Publicado: (2023)

Regulation of p53 and Cancer Signaling by Heat Shock Protein 40/J-Domain Protein Family Members
por: Kaida, Atsushi, et al.
Publicado: (2021)

Regulators of Oncogenic Mutant TP53 Gain of Function
por: Yamamoto, Satomi, et al.
Publicado: (2018)

Ubiquitination of mammalian AP endonuclease (APE1) regulated by the p53-MDM2 signaling pathway
por: Busso, Carlos S., et al.
Publicado: (2009)

A novel link between the HER2-Akt and MDM2-p53 pathways via CSN6
por: Iyer, Swathi V., et al.
Publicado: (2012)

DNAJA1- and conformational mutant p53-dependent inhibition of cancer cell migration by a novel compound identified through a virtual screen
por: Nishikawa, Shigeto, et al.
Publicado: (2022)

Mutant p53 Depletion by Novel Inhibitors for HSP40/J-Domain Proteins Derived from the Natural Compound Plumbagin
por: Alalem, Mohamed, et al.
Publicado: (2022)

Characterization of an Mtbp Hypomorphic Allele in a Diethylnitrosamine-Induced Liver Carcinogenesis Model
por: Ranjan, Atul, et al.
Publicado: (2023)

The Role of Tumor Protein 53 Mutations in Common Human Cancers and Targeting the Murine Double Minute 2–P53 Interaction for Cancer Therapy
por: Hamzehloie, Tayebeh, et al.
Publicado: (2012)

Novel siRNA formulation to effectively knockdown mutant p53 in osteosarcoma
por: Kundu, Anup K., et al.
Publicado: (2017)

Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities
por: Iyer, Swathi V., et al.
Publicado: (2015)

p53-Independent Induction of p21 Fails to Control Regeneration and Hepatocarcinogenesis in a Murine Liver Injury Model
por: Buitrago-Molina, Laura Elisa, et al.
Publicado: (2021)

Apoptosis of Sertoli cells after conditional ablation of murine double minute 2 (Mdm2) gene is p53-dependent and results in male sterility
por: Fouchécourt, S, et al.
Publicado: (2016)

The fate of murine double minute X (MdmX) is dictated by distinct signaling pathways through murine double minute 2 (Mdm2)
por: Hauck, Paula M., et al.
Publicado: (2017)

Silencing Ribosomal Protein L22 Promotes Proliferation and Migration, and Inhibits Apoptosis of Gastric Cancer Cells by Regulating the Murine Double Minute 2-Protein 53 (MDM2-p53) Signaling Pathway
por: Sun, Zhenqing, et al.
Publicado: (2021)

Considering the Role of Murine Double Minute 2 in the Cardiovascular System?
por: Lam, Brian, et al.
Publicado: (2019)

Immunohistochemical Detection and Prognostic Significance of p53, Epidermal Growth Factor Receptor, Murine Double Minute 2, and Isocitrate Dehydrogenase 1 in Glioblastoma Multiforme Patients of Pakistan
por: Ali, Syed Muhammad Adnan, et al.
Publicado: (2022)

The interplay between physical cues and mechanosensitive ion channels in cancer metastasis
por: Bera, Kaustav, et al.
Publicado: (2022)

Regional localisation of p53-independent apoptosis determines toxicity to 5-fluorouracil and pyrrolidinedithiocarbamate in the murine gut
por: Bach, S P, et al.
Publicado: (2006)

Autoantibody Response to Murine Double Minute 2 Protein in Immunodiagnosis of Hepatocellular Carcinoma
por: Liu, Mei, et al.
Publicado: (2014)

Farnesoid X receptor functions in cervical cancer via the p14(ARF)-mouse double minute 2-p53 pathway
por: Huang, Xiaohua, et al.
Publicado: (2022)

Suppression of pancreatic cancer liver metastasis by secretion-deficient ITIH5
por: Young, Eric D., et al.
Publicado: (2020)

Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation
por: Matsuzoe, D, et al.
Publicado: (1999)

p53-Autophagy-Metastasis Link
por: Denisenko, Tatiana V., et al.
Publicado: (2018)

Genome-wide RNAi screening identifies TMIGD3 isoform1 as a suppressor of NF-κB and osteosarcoma progression
por: Iyer, Swathi V., et al.
Publicado: (2016)

Suppression of pancreatic cancer growth and metastasis by HMP19 identified through genome‐wide shRNA screen
por: Kurahara, Hiroshi, et al.
Publicado: (2016)

Integration of DNA Damage and Repair with Murine Double-Minute 2 (Mdm2) in Tumorigenesis
por: Lehman, Jason A., et al.
Publicado: (2012)

Mutant p53 regulates Survivin to foster lung metastasis
por: Tang, Qiaosi, et al.
Publicado: (2021)

Tumor suppressing role of serum-derived exosomal microRNA-15a in osteosarcoma cells through the GATA binding protein 2/murine double minute 2 axis and the p53 signaling pathway
por: Wu, Chunyu, et al.
Publicado: (2021)

The Double Role of p53 in Cancer and Autoimmunity and Its Potential as Therapeutic Target
por: Fierabracci, Alessandra, et al.
Publicado: (2016)

p19( Arf) Suppresses Growth, Progression, and Metastasis of Hras-Driven Carcinomas through p53-Dependent and -Independent Pathways
por: Kelly-Spratt, Karen S, et al.
Publicado: (2004)

Murine Double-Minute 2 Homolog Single Nucleotide Polymorphisms 285 and 309 in Cervical Carcinogenesis
por: Roszak, Andrzej, et al.
Publicado: (2015)

Induction of p53-dependent and p53-independent cellular responses by topoisomerase 1 inhibitors.
por: McDonald, A. C., et al.
Publicado: (1998)

p53-dependent and p53-independent anticancer effects of different histone deacetylase inhibitors
por: Sonnemann, J, et al.
Publicado: (2014)

Loss of SET reveals both the p53-dependent and the p53-independent functions in vivo
por: Kon, Ning, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8sbgr16svlmr7j988r2kknutn5